2017
DOI: 10.1093/neuonc/nox066
|View full text |Cite
|
Sign up to set email alerts
|

Cerebrospinal fluid circulating tumor cells: a novel tool to diagnose leptomeningeal metastases from epithelial tumors

Abstract: We defined ≥1 CSF-CTC/mL as the optimal cutoff for diagnosis of LM. CSF-CTC enumeration through RCCT is a robust tool to diagnose LM and should be considered in the routine LM workup in solid tumor patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
69
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
5
1
1

Relationship

2
5

Authors

Journals

citations
Cited by 91 publications
(75 citation statements)
references
References 29 publications
0
69
0
Order By: Relevance
“…Limited by several technical constraints, previous somewhat coarse analyses provided limited diagnostic information or pathophysiologic insight. Modern, highly granular analytic approaches to CSF, or “liquid biopsies,” have the potential to greatly improve diagnostic sensitivity of LMD, guide treatment decisions, and drive discovery (Boire et al, , ; Lin et al, ; Miller et al, ). There are two main liquid biopsy approaches currently in use in LMD: circulating tumor cell analysis (CTCs) and cell‐free tumor DNA sequencing (ctDNA); these are reviewed in detail below.…”
Section: Circulating Tumor Cells and Cell‐free Dnamentioning
confidence: 99%
See 1 more Smart Citation
“…Limited by several technical constraints, previous somewhat coarse analyses provided limited diagnostic information or pathophysiologic insight. Modern, highly granular analytic approaches to CSF, or “liquid biopsies,” have the potential to greatly improve diagnostic sensitivity of LMD, guide treatment decisions, and drive discovery (Boire et al, , ; Lin et al, ; Miller et al, ). There are two main liquid biopsy approaches currently in use in LMD: circulating tumor cell analysis (CTCs) and cell‐free tumor DNA sequencing (ctDNA); these are reviewed in detail below.…”
Section: Circulating Tumor Cells and Cell‐free Dnamentioning
confidence: 99%
“…New semi‐automated cell assays have been applied with some success to melanoma as well as other solid tumors for the purpose of diagnosing LMD (Le Rhun, Tu, et al, ; Lin et al, , #1447). In the largest cohort ( n = 95, 36 breast, 31 lung, 28 others) to date, a cutoff of ≥1 CSF‐CTC/ml provided the best threshold to diagnose LMD, achieving a sensitivity of 93%, specificity of 95%, positive predictive value 90%, and negative predictive value 97% (Lin et al, ). Other methods, such as flow cytometry, have proved disappointing due to inconsistent surface marker expression.…”
Section: Circulating Tumor Cells and Cell‐free Dnamentioning
confidence: 99%
“…The rates of sensitivity were 95% for CSF CTCs compared with 81% for CSF cytology alone and 62% for MRI alone. 110 The rate of specificity was 83%. 110 Thus, this method had superior diagnostic performance when compared with CSF cytology or MRI.…”
mentioning
confidence: 93%
“…110 The rate of specificity was 83%. 110 Thus, this method had superior diagnostic performance when compared with CSF cytology or MRI.…”
mentioning
confidence: 93%
See 1 more Smart Citation